Scientists use nanoparticles to shut down mechanism that drives cancer growth

Friday, July 3, 2015 - 05:00 in Health & Medicine

When scientists develop cancer therapies, they target the features that make the disease deadly: tumor growth, metastasis, recurrence and drug resistance. In epithelial cancers—cancers of the breast, ovaries, prostate, skin and bladder, which begin in the organs' lining—these processes are controlled by a genetic program called epithelial–mesenchymal transition.

Read the whole article on Physorg

More from Physorg

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net